COMMUNIQUÉS West-GlobeNewswire

Aptevo Therapeutics Highlights Key 2019 Priorities
07/01/2019
ADAPTIR™ Bispecific Antibody Candidates Poised to Progress in Clinical Development APVO436 Advancing in Phase 1 Clinical Trial for Acute Myeloid Leukemia; APVO210 Beginning Phase 1 Clinical Trial in Q1 2019; ALG.APV-527 [...]
OrthoPediatrics Corp. Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2018
07/01/2019
WARSAW, Ind., Jan. 07, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its preliminary unaudited revenue for [...]
Checkpoint Therapeutics Initiates Registrational Development Programs for Anti-PD-L1 Antibody CK-301
07/01/2019
Ongoing endometrial and colorectal cancer cohorts intended to support BLA submissions NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno- [...]
Enochian Biosciences Announces Appointment of Dr. Mark Dybul as Executive Vice-Chair
07/01/2019
LOS ANGELES, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Enochian Biosciences, Inc. (“Enochian”) a biopharmaceutical company focused on the development and commercialization of novel therapies for HIV/AIDS and oncology, announced [...]
SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2018
07/01/2019
CARLSBAD, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
Cellectar Provides Update on Phase 1 Trial of CLR 131 in Relapsed/Refractory Multiple Myeloma
07/01/2019
Median overall survival of 22.0 months observed in Cohorts 1-4 FLORHAM PARK, N.J., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the [...]
Aura Announces Non-Brokered Private Placement of Up to $1,500,000
07/01/2019
TORONTO, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the " Company " or “ Aura ”) ( CSE:BUZZ ) is pleased to announce that it is raising up to $1,500,000 by way of a non-brokered private placement of units of [...]
Allscripts Joins with Microsoft to Explore Technology for Clinical Research
07/01/2019
A new operating model to enable research as a natural output of clinical practice, through integration with point-of-care technology platforms and workflows CHICAGO, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Today, Allscripts ( [...]
Sientra Announces Preliminary Unaudited Fourth Quarter 2018 Net Sales and Appointment of Aesthetic Industry Veteran to Board of Directors
07/01/2019
Anticipates total fourth quarter net sales of $19.0 million, growth of 72% year over year Aesthetic industry veteran Mary M. Fisher joins Sientra’s Board of Directors SANTA BARBARA, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE [...]
BioTime Enters Into Exclusive Agreement With Orbit Biomedical Ltd. to Access Innovative Device for the Sub-Retinal Delivery of OpRegen® Cells for the Treatment of Dry-AMD
07/01/2019
ALAMEDA, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it has entered into a [...]
Allakos Announces Positive Phase 2 Results in a Cohort of Xolair-Naïve Chronic Spontaneous Urticaria Patients
07/01/2019
-- 12 of 13 (92%) patients achieved a complete response -- -- Results from 3 additional cohorts expected in the first quarter of 2019 -- REDWOOD CITY, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Allakos Inc. (NASDAQ: ALLK [...]
Neuronetics Announces Preliminary Fourth Quarter and Full Year Revenue
07/01/2019
Preliminary full year 2018 total revenue of approximately $52.8 million, an increase of approximately 31% over the full year 2017, exceeding previously issued guidance MALVERN, Pa., Jan. 07, 2019 (GLOBE NEWSWIRE) -- [...]
Long-Term Study of 1,000 Tumors Demonstrates Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment
07/01/2019
Prospective trial shows that intraoperative radiation therapy (IORT) is a clinically effective, faster and easier alternative to whole breast radiation therapy following breast-conserving surgery for selected low-risk [...]
Aulisa Medical USA, Inc. Enters Market With Wearable, Wireless Continuous Vital Signs Monitoring & Alarm Systems
07/01/2019
Remote Vitals Monitoring Technology for Medical Use PALO ALTO, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Aulisa Medical USA, Inc. today released the first of its Guardian Angel TM Rx line of wireless, wearable [...]
Rubius Therapeutics Highlights Upcoming 2019 Milestones at the 37th Annual J.P. Morgan Healthcare Conference
07/01/2019
CAMBRIDGE, Mass., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company that is generating red blood cells and bioengineering them into an entirely new class of cellular [...]
Tabula Rasa HealthCare Completes Acquisition of DoseMe
07/01/2019
MOORESTOWN, N.J., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced that it completed its [...]
Tauriga Sciences, Inc. to Launch an E-Commerce Site to Coincide with the Commercial Launch of its Cannabis/CBD Infused Chewing Gum Product Line
07/01/2019
NEW YORK, NY, Jan. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]
Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy
07/01/2019
Preparing Three Lead Programs for MLD, ADA-SCID and WAS for Regulatory Filings Over the Next Three Years Recently Announced Clinical Proof-of-Concept in X-CGD Demonstrates Platform’s Transformative Potential Advancing [...]
CareDx Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results
07/01/2019
BRISBANE, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]

Pages